References
- 1Mikulska M, Lanini S, Gudiol C, et al. ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: An infectious diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52). Clin Microbiol Infect. 2018; 24(Suppl 2): S71–S82. DOI: 10.1016/j.cmi.2018.02.003
- 2Scerra S, Coignard-Biehler H, Lanternier F, et al. Disseminated toxoplasmosis in non-allografted patients with hematologic malignancies: Report of two cases and literature review. Eur J Clin Microbiol Infect Dis. 2013; 32(10): 1259–1268. DOI: 10.1007/s10096-013-1879-8
- 3Abedalthagafi M, Rushing EJ, Garvin D, Cheson B, Ozdemirli M. Asymptomatic diffuse “encephalitic” cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia: Case report and review of the literature. Int J Clin Exp Pathol. 2009; 3(1): 106–109.
- 4Savsek L, Opaskar TR. Cerebral toxoplasmosis in a diffuse large B cell lymphoma patient. Radiol Oncol. 2016; 50(1): 87–93. DOI: 10.1515/raon-2014-0042
- 5Bacchu S, Fegan C, Neal J. Cerebral toxoplasmosis in a patient with chronic lymphocytic leukaemia treated with fludarabine. Br J Haematol. 2007; 139(3): 349. DOI: 10.1111/j.1365-2141.2007.06774.x
- 6Montoya JG, Liesenfeld O. Toxoplasmosis. Lancet. 2004; 363(9425): 1965–1976. DOI: 10.1016/S0140-6736(04)16412-X
- 7Chong-Han CH, Cortez SC, Tung GA. Diffusion-weighted MRI of cerebral toxoplasma abscess. AJR Am J Roentgenol. 2003; 181(6): 1711–1714. DOI: 10.2214/ajr.181.6.1811711
- 8Masamed R, Meleis A, Lee EW, Hathout GM. Cerebral toxoplasmosis: Case review and description of a new imaging sign. Clin Radiol. 2009; 64(5): 560–563. DOI: 10.1016/j.crad.2008.09.016
- 9Kumar GG, Mahadevan A, Guruprasad AS, et al. Eccentric target sign in cerebral toxoplasmosis: Neuropathological correlate to the imaging feature. J Magn Reson Imaging. 2010; 31(6): 1469–1472. DOI: 10.1002/jmri.22192
- 10da Cunha Correia C, Ramos Lacerda H, de Assis Costa VM, Mertens de Queiroz Brainer A. Cerebral toxoplasmosis: Unusual MRI findings. Clin Imaging. 2012; 36(5): 462–465. DOI: 10.1016/j.clinimag.2012.01.019
- 11Benson JC, Cervantes G, Baron TR, et al. Imaging features of neurotoxoplasmosis: A multiparametric approach, with emphasis on susceptibility-weighted imaging. Eur J Radiol Open. 2018; 5: 45–51. DOI: 10.1016/j.ejro.2018.03.004
- 12Xu J, Nault RJ, Maldonado-Naranjo A, et al. Disseminated cerebral toxoplasmosis in a patient with chronic lymphocytic leukemia. J Clin Neurosci. 2018; 50: 127–128. DOI: 10.1016/j.jocn.2018.01.057